X-154534389-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_001360016.2(G6PD):c.593G>A(p.Arg198His) variant causes a missense change. The variant allele was found at a frequency of 0.000000911 in 1,097,977 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R198S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001360016.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.593G>A | p.Arg198His | missense_variant | 6/13 | ENST00000393562.10 | NP_001346945.1 | |
G6PD | NM_000402.4 | c.683G>A | p.Arg228His | missense_variant | 6/13 | NP_000393.4 | ||
G6PD | NM_001042351.3 | c.593G>A | p.Arg198His | missense_variant | 6/13 | NP_001035810.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
G6PD | ENST00000393562.10 | c.593G>A | p.Arg198His | missense_variant | 6/13 | 1 | NM_001360016.2 | ENSP00000377192.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097977Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 1AN XY: 363345
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 15, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg198 amino acid residue in G6PD. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1551674, 7789945, 11499668, 16155737, 16927025). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 198 of the G6PD protein (p.Arg198His). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with glucose-6-phosphate dehydrogenase deficiency (PMID: 18043863, 29333274). ClinVar contains an entry for this variant (Variation ID: 10417). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. - |
Pathogenic, criteria provided, single submitter | curation | Dunham Lab, University of Washington | Aug 12, 2022 | Variant found in unrelated hemizygotes with deficiency (PS4_M, PP4). In one family, hemizygote son has deficiency, heterozygous mother has decreased G6PD activity (PP1); in another family, hemizygote son inherited variant from heterozygote mother, but neither maternal grandparent has variant, suggesting de novo (PM6). Decreased activity in red blood cells (1%) and when expressed in yeast (60%) (PS3). Located in substrate binding site (PM1). Not found in gnomAD (PM2). Reported as pathogenic by Mendelics (PP5). Post_P 0.9998 (odds of pathogenicity 59154, Prior_P 0.1). - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Malaria, susceptibility to Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 23, 2024 | - - |
G6PD NILGIRI Other:1
other, no assertion criteria provided | literature only | OMIM | May 24, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at